Reverse remodeling in heart failure—mechanisms and therapeutic opportunities

被引：0
作者：
Norimichi Koitabashi
David A. Kass
机构：
[1] Gunma University Graduate School of Medicine,Department of Medicine and Biological Sciences
[2] Johns Hopkins Medical Institutions,Division of Cardiology, Department of Medicine
来源：
Nature Reviews Cardiology | 2012年 / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Understanding mechanisms of cardiac remodeling, with the goal of developing therapies to stop or reverse its progression, has become a major objective for investigators of heart failure. In this Review, Dr Koitabashi and Professor Kass discuss the evidence for 'reverse remodeling' by existing therapies, and review novel approaches that are currently moving from preclinical to clinical trials.
引用
收藏
页码：147 / 157
页数：10
相关论文
共 230 条
[1]  
Lloyd-Jones D(2010)Heart disease and stroke statistics—2010 update: a report from the American Heart Association Circulation 121 e46-e215
[2]  
Cohn JN(2000)Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling J. Am. Coll. Cardiol. 35 569-582
[3]  
Ferrari R(2006)Controversies in ventricular remodelling Lancet 367 356-367
[4]  
Sharpe N(2010)Molecular pathways underlying cardiac remodeling during pathophysiological stimulation Circulation 122 2727-2735
[5]  
Opie LH(2007)Reversing chronic remodeling in heart failure Expert Rev. Cardiovasc. Ther. 5 585-598
[6]  
Commerford PJ(1985)Influence of chronic captopril therapy on the infarcted left ventricle of the rat Circ. Res. 57 84-95
[7]  
Gersh BJ(1979)Left ventricular radius to wall thickness ratio Am. J. Cardiol. 43 1189-1194
[8]  
Pfeffer MA(2002)Genetic alterations that inhibit Circulation 105 85-92
[9]  
Kehat I(2006) pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress J. Clin. Invest. 116 1547-1560
[10]  
Molkentin JD(2004)Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction Circulation 110 1456-1462
12345678910